Drug Coverage and Cost-Effectiveness

Survey of healthcare decision makers found that preapproval information exchange could have a positive impact on shortening formulary decision-making timelines Read More ›

Multi-cancer early detection screening can achieve better cancer detection and comparable or improved cost-effectiveness Read More ›

An analysis found that commercial health insurers do not issue coverage policies more quickly for specialty drugs approved through FDA-expedited review programs Read More ›

Analysis of health plans examines the variability in specialty drug coverage among medical and pharmacy benefit policies Read More ›

Conference Correspondent Coverage is Brought to You by the Publishers of:
The Oncology Pharmacist
Value-Based Cancer Care

Learn more about our family of publications.

View Our Publications